FDA Inspection 1009402 — Intersect ENT, Inc.
The FDA completed an inspection of Intersect ENT, Inc. on April 6, 2017 in Menlo Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Menlo Park, CA (United States)